BIP Capital Partners

Skip to content

HOME
About us
- OUR TEAM
- OUR HISTORY
- ESG
- BIP IV
investment approach
- INVESTMENT APPROACH
- INVESTMENT CHARACTERISTICS
portfolio
- SELECTED INVESTMENTS
- SELECTED EXITS
News
CONTACT

BIP announces the sale of its investment in lifebrain

Post navigation

Previous PostBIP exits ENZYMOTEC: originally a private equity investment, quoted on the NASDAQ in 2013 Next PostBIP announces an investment in pluss, a German temporary staffing company

© BIP Group Luxembourg 2025

Stay in touch with us, leave your email